Ted English

Ted brings many years of experience in accounting and financial reporting for rapidly evolving biotechnology companies. Most recently he was VP Finance, Accounting and Treasury at Xilio Therapeutics in Waltham, and prior to that he worked in a similar capacity at research and commercial biopharmaceutical companies such as Evelo Biosciences, TESARO, AMAG Pharmaceuticals and Praecis Pharmaceuticals. Ted spent the first several years of his career at KPMG, an independent public accounting firm, and obtained his MSA/MBA from Northeastern University and BSBA from Georgetown University.